Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series

BackgroundRituximab (RTX) has gradually been accepted as a treatment for frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS) in children, but no standardized recommendations for the dosage and combination therapy exist. Additionally, the efficacy and safety...

Full description

Saved in:
Bibliographic Details
Main Authors: Jide Song, Hong Chang, Yi Lin, Chunrong Shan, Jia Liu, Ranran Zhang, Nana Nie, Cui Bai, Shan Gao, Qiuye Zhang, Dahai Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pharmacology
Subjects:
rituximab
mycophenolate mofetil
frequently relapsing nephrotic syndrome
steroid-dependent nephrotic syndrome
children
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1646837/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1646837/full

Similar Items